Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Hema Samaratunga"'
Autor:
Raymond A Clarke, Zhongming Zhao, An-Yuan Guo, Kathrein Roper, Linda Teng, Zhi-Ming Fang, Hema Samaratunga, Martin F Lavin, Robert A Gardiner
Publikováno v:
PLoS ONE, Vol 4, Iss 3, p e4995 (2009)
The prostate cancer antigen 3 (PCA3/DD3) gene is a highly specific biomarker upregulated in prostate cancer (PCa). In order to understand the importance of PCA3 in PCa we investigated the organization and evolution of the PCA3 gene locus.We have empl
Externí odkaz:
https://doaj.org/article/1d2912b349ea415ca2dea8bbbdcafbc9
Autor:
R. Esler, Brett Delahunt, William Yaxley, G. Coughlin, D. Wong, Hema Samaratunga, Boon Kua, R. Parkinson, John Yaxley, Sheliyan Raveenthiran, Matthew J. Roberts, T. Franklin, Louise McEwan, Nicholas Brown, Troy Gianduzzo, Lars Egevad
Publikováno v:
Journal of Urology. 207:573-580
Purpose:Multiparametric magnetic resonance imaging (mpMRI) fails to identify some men with significant prostate cancer. Prostate-specific membrane antigen positron emission tomography/computerized ...
Autor:
R. Parkinson, Brett Delahunt, Lousie McEwan, John Yaxley, Matthew J. Roberts, Hema Samaratunga, Geoff Coughlin, Anthony Franklin, Boon Kua, David Wong, Sheliyan Raveenthiran, Nicholas Brown, Troy Gianduzzo, Lars Egevad, William Yaxley
Publikováno v:
BJU International. 127:71-79
Objective To evaluate the ability of preoperative multiparametric magnetic resonance imaging (mpMRI) and a gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography (Ga-68-PSMA PET/CT) scan to predict pathological
Autor:
Hema Samaratunga, Anthony Franklin, Troy Gianduzzo, John Yaxley, Geoff Coughlin, T. Gianduzzo, Boon Kua
Publikováno v:
BJU International. 126:6-11
Objectives: To describe the use of a novel 'trizonal' biopsy schema in which 'near-target' biopsies are taken adjacent to the MRI lesion, in addition to target and systematic biopsies, to determine the accuracy of prostate MRI fusion systems. Partici
Autor:
Anthony, Franklin, William J, Yaxley, Sheliyan, Raveenthiran, Geoff, Coughlin, Troy, Gianduzzo, Boon, Kua, Lousie, McEwan, David, Wong, Brett, Delahunt, Lars, Egevad, Hema, Samaratunga, Nicholas, Brown, Rob, Parkinson, Matthew J, Roberts, John W, Yaxley
Publikováno v:
BJU internationalReferences. 127(1)
To evaluate the ability of preoperative multiparametric magnetic resonance imaging (mpMRI) and a gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography (Between July 2014 and September 2019 only men who had bot
Autor:
Anthony, Franklin, Tony, Gianduzzo, John, Yaxley, Boon, Kua, Geoff, Coughlin, Hema, Samaratunga, Troy, Gianduzzo
Publikováno v:
BJU internationalReferences. 126
To describe the use of a novel 'trizonal' biopsy schema in which 'near-target' biopsies are taken adjacent to the MRI lesion, in addition to target and systematic biopsies, to determine the accuracy of prostate MRI fusion systems.A trizonal biopsy te
Autor:
Hema Samaratunga, Renee S. Richards, Paul N. Mainwaring, Kevin M. Koo, Yuling Wang, Matt Trau, Matthew J. Roberts, John Yaxley, Martin F. Lavin, G. Coughlin, Jing Wang, Aine Farrell, Robert A. Gardiner, Patrick Teloken
Publikováno v:
ACS Nano. 12:8362-8371
The use of emerging nanotechnologies, such as plasmonic nanoparticles in diagnostic applications, potentially offers opportunities to revolutionize disease management and patient healthcare. Despite worldwide research efforts in this area, there is s
Publikováno v:
BJU International. 120:56-60
Objective To evaluate the long term outcome of high dose rate brachytherapy (HDR) for patients with intermediate and high risk prostate cancer Subjects, Patients and Methods We retrospectively analysed the prospective longitudinal cohort data base of
Autor:
Troy Gianduzzo, Suzanne K. Chambers, Renee S. Richards, Hema Samaratunga, Suhail A.R. Doi, Robyn J Medcraft, Robert A. Gardiner, Joanna Perry-Keene, Rachel Esler, Nicholas Kienzle, Matthew J. Roberts, Macy Lu, Martin F. Lavin, Diane Payton, Nigel Dunglison, G. Coughlin, Horst Joachim Schirra, Ian M. Brereton, Clement W. K. Chow, John Yaxley, Chikara Oyama
Publikováno v:
Contemporary Clinical Trials. 50:16-20
Background Atorvastatin and metformin are known energy restricting mimetic agents that act synergistically to produce molecular and metabolic changes in advanced prostate cancer (PCa). This trial seeks to determine whether these drugs favourably alte
Autor:
Hema Samaratunga, Leah Zaidlewicz, Scott Williams, Rob Carter, Diane Payton, Stefano Occhipinti, Martin F. Lavin, G. Coughlin, Nigel Dunglison, Joanna Perry-Keene, John Yaxley, Robert A. Gardiner, Suzanne K. Chambers
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 12:26-33